Literature DB >> 22834823

Analogous effects of recombinant human full-length amelogenin expressed by Pichia pastoris yeast and enamel matrix derivative in vitro.

L Cheng1, Z K Lin, R Shu, D L Liu, X L Zhang, B Liu, J Wang, L Tian.   

Abstract

OBJECTIVES: Amelogenins are proposed to be responsible for enamel matrix derivative (EMD)-induced periodontal regeneration; however, heterogeneity of amelogenins makes it challenging to purify the full-length proteins. This study has been carried out to express and purify a recombinant full-length human amelogenin protein (rHhAm175) in the eukaryotic yeast Pichia pastoris, and further compare biological responses of human periodontal ligament fibroblasts (PDLFs) to rHhAm175 and porcine EMD (pEMD).
MATERIALS AND METHODS: Human cDNA encoding a 175-amino acid amelogenin was subcloned into the pPIC3.5K vector. The rHhAm175 expressed in P. pastoris GS115 (Mut+) was purified and characterized. We examined cell attachment, migration and proliferation responses of human PDLFs to rHhAm175 and pEMD respectively, and characterized associated changes of proliferation-related intracellular signalling molecules, including extracellular signal response kinase (ERK) and Akt kinases/protein kinase B (Akt/PKB) kinases.
RESULTS: The purified rHhAm175 was confirmed to be molecular mass 22 021.13 Da, phosphorylated human amelogenin, and alone significantly promoted proliferation and migration of human PDLFs to an extent comparable to that of pEMD. Cell attachment was increased over the first 60 min incubation with rHhAm175 or pEMD. Both rHhAm175 and pEMD induced PDLF mitogenesis via extracellular signal response kinase (ERK1/2), but not by Akt kinases/protein kinase B (Akt/PKB).
CONCLUSIONS: rHhAm175 modulated cell activities of human PDLFs, to a comparable extent as porcine EMD. These data suggest that rHhAm175 might be used to induce periodontal tissue regeneration.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22834823      PMCID: PMC6495870          DOI: 10.1111/j.1365-2184.2012.00834.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  34 in total

1.  Human amelogenin up-regulates osteogenic gene expression in human bone marrow stroma cells.

Authors:  Hu Jingchao; Shu Rong; Song Zhongchen; Chen Lan
Journal:  Biochem Biophys Res Commun       Date:  2011-04-13       Impact factor: 3.575

2.  Nanometer analysis of cell spreading on matrix-coated surfaces reveals two distinct cell states and STEPs.

Authors:  Benjamin J Dubin-Thaler; Gregory Giannone; Hans-Günther Döbereiner; Michael P Sheetz
Journal:  Biophys J       Date:  2004-03       Impact factor: 4.033

3.  Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro.

Authors:  Joan M Lemire; Mervyn J Merrilees; Kathleen R Braun; Thomas N Wight
Journal:  J Cell Physiol       Date:  2002-01       Impact factor: 6.384

4.  High expression of human amelogenin in E. coli.

Authors:  D Deutsch; E Chityat; M Hekmati; A Palmon; Y Farkash; L Dafni
Journal:  Adv Dent Res       Date:  1996-11

5.  Enamel matrix derivative stimulates human gingival fibroblast proliferation via ERK.

Authors:  E Zeldich; R Koren; C Nemcovsky; M Weinreb
Journal:  J Dent Res       Date:  2007-01       Impact factor: 6.116

6.  Effects of human full-length amelogenin on the proliferation of human mesenchymal stem cells derived from bone marrow.

Authors:  Yu-Ching Huang; Kotaro Tanimoto; Yuki Tanne; Takashi Kamiya; Ryo Kunimatsu; Masahiko Michida; Motoko Yoshioka; Yuki Yoshimi; Yukio Kato; Kazuo Tanne
Journal:  Cell Tissue Res       Date:  2010-10-22       Impact factor: 5.249

7.  Human periodontal ligament and gingival fibroblast response to TGF-beta 1 stimulation.

Authors:  J M Mailhot; G S Schuster; J J Garnick; P J Hanes; C A Lapp; J B Lewis
Journal:  J Clin Periodontol       Date:  1995-09       Impact factor: 8.728

8.  The influence of enamel matrix derivative associated with insulin-like growth factor-I on periodontal ligament fibroblasts.

Authors:  Daniela B Palioto; Ricardo D Coletta; Edgard Graner; Julio Cesar Joly; Antonio Fernando Martorelli de Lima
Journal:  J Periodontol       Date:  2004-04       Impact factor: 6.993

9.  EGFR in Enamel Matrix Derivative-induced gingival fibroblast mitogenesis.

Authors:  E Zeldich; R Koren; M Dard; C Nemcovsky; M Weinreb
Journal:  J Dent Res       Date:  2008-09       Impact factor: 6.116

10.  Effects of enamel matrix derivative and transforming growth factor-beta1 on human periodontal ligament fibroblasts.

Authors:  Thaisângela L S Rodrigues; Julie T Marchesan; Ricardo D Coletta; Arthur B Novaes; Márcio F de M Grisi; Sérgio L S Souza; Mário Taba; Daniela B Palioto
Journal:  J Clin Periodontol       Date:  2007-06       Impact factor: 8.728

View more
  4 in total

1.  Cloning and Expression Analysis of Human Amelogenin in Nicotiana benthamiana Plants by Means of a Transient Expression System.

Authors:  Mattia Pegoraro; Slavica Matić; Barbara Pergolizzi; Luca Iannarelli; Andrea M Rossi; Marco Morra; Emanuela Noris
Journal:  Mol Biotechnol       Date:  2017-10       Impact factor: 2.695

2.  The effects of synthetic oligopeptide derived from enamel matrix derivative on cell proliferation and osteoblastic differentiation of human mesenchymal stem cells.

Authors:  Nobuhito Katayama; Hirohito Kato; Yoichiro Taguchi; Akio Tanaka; Makoto Umeda
Journal:  Int J Mol Sci       Date:  2014-08-13       Impact factor: 5.923

3.  Expression of Recombinant Human Amelogenin in Iranian Lizard Leishmania and Its Biological Function Assay.

Authors:  Zahra Yadegari; Mojgan Bandehpour; Bahram Kazemi; Khojasteh Sharifi-Sarasiabi
Journal:  Iran J Public Health       Date:  2015-07       Impact factor: 1.429

4.  Preparative SDS PAGE as an Alternative to His-Tag Purification of Recombinant Amelogenin.

Authors:  Claire M Gabe; Steven J Brookes; Jennifer Kirkham
Journal:  Front Physiol       Date:  2017-06-16       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.